Creative medical technology appoints sahil nock as chief commercial officer

Phoenix, ariz. , march 2, 2022 /prnewswire/ -- creative medical technology holdings, inc. ("creative medical technology" or the "company") (nasdaq: celz), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced the appointment of sahil nock as the company's chief commercial officer, effective february 28, 2022.
CELZ Ratings Summary
CELZ Quant Ranking